Johne's disease

The team will employ reverse vaccinology coupled with high-throughput genomics approaches, such as RNA-seq, to deliver the new vaccines within four years.

Life Technologies said this week that it has signed an agreement with Copan Flock to provide an integrated, end-to-end system for DNA forensics.

NEW YORK (GenomeWeb News) – GeneThera announced today that its wholly owned subsidiary Applied Genetics has signed a deal with the Universidad National Autonoma de Mexico to validate GeneThera's platform for Johne's disease.

GeneThera is currently negotiating formal licensing agreements with the Universita di Roma "Tor Vegata" and Universita Cattolica del Sacro Cuore, which have jointly developed a potential liposome-based therapeutic for Johne's disease, an uncurable bacterial disease affecting the intestinal tract of livestock.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.